Cloning Human Antibodies
ISAB integrates REAP (autoantibody profiling across 6,500+ antigens) with the TRABI high-throughput platform (40,000 ELISAs/day) and clinical biobank samples.
The goal is to identify disease-relevant signatures, stratify patients using machine learning, and clone protective human antibodies from high-affinity responders.